New drug combo aims to control deadly brain tumors
NCT ID NCT02331498
First seen May 08, 2026 · Last updated May 08, 2026
Summary
This study tests whether adding the drug pazopanib to standard chemotherapy (temozolomide) can help control glioblastoma, a fast-growing brain cancer. About 51 adults who have had surgery and initial chemoradiation will take the combination. The goal is to find a safe dose and see if it improves outcomes, though lifelong treatment is expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Antoine Lacassagne
Nice, Cedex 2, 06189, France
Conditions
Explore the condition pages connected to this study.